Rheos Medicines attracts $60 mln Series A
Cambridge, Massachusetts-based Rheos Medicines, a biopharmaceutical company, has raised $60 million in Series A funding. The investor was Third Rock Ventures.
22 March 2018•1 min read
Cambridge, Massachusetts-based Rheos Medicines, a biopharmaceutical company, has raised $60 million in Series A funding. The investor was Third Rock Ventures.
